BIOTECH ACQUISITION COMPANY - CL A SHS (BIOT)

CUSIP: G1125A108

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / CL A SHS
Total 13F shares
22,063,008
Share change
+579,189
Total reported value
$217,440,000
Price per share
$9.86
Number of holders
75
Value change
+$5,735,382
Number of buys
18
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP G1125A108?
CUSIP G1125A108 identifies BIOT - BIOTECH ACQUISITION COMPANY - CL A SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - CL A SHS (BIOT) as of Q1 2022

As of 31 Mar 2022, BIOTECH ACQUISITION COMPANY - CL A SHS (BIOT) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,063,008 shares. The largest 10 holders included ARISTEIA CAPITAL LLC, D. E. Shaw & Co., Inc., Corbin Capital Partners, L.P., MARSHALL WACE, LLP, Saba Capital Management, L.P., CITADEL ADVISORS LLC, Omni Event Management Ltd, RiverPark Advisors, LLC, Cohanzick Management, LLC, and Periscope Capital Inc.. This page lists 75 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.